American Association for Cancer Research

AACR CANCER POLICY MONITOR

CPM

                                                                                                    JULY 2010


CONGRESS STILL STALLED ON RESEARCH APPROPRIATIONS

November elections overshadow work on Capitol Hill

Congress returns from the Fourth of July recess this week with a full schedule before legislators pack up again for an extended August recess. Read more

 


 

OP-ED: FINDING MY VOICE AND MAKING A DIFFERENCE

By Aime T. Franco, Ph.D.

Eleven years ago I was diagnosed with thyroid cancer. I am fortunate that the cancer was caught early and that I have been cancer-free for 10 years, but that experience will always stay with me. It solidified my career choice as a cancer researcher and strengthened my resolve to do everything I could to make sure others would not have to hear those words, "yes, it is cancer." Read more

 


 

REPORT RELEASED BY AACR-FDA-NCI CANCER BIOMARKERS COLLABORATIVE

Report identifies areas for biomarker development & strategies to accelerate cancer therapies to patients

The rate at which biomarkers are discovered far outpaces the rate at which that information is translated to patient benefit. This challenge has been a primary focus of the Cancer Biomarkers Collaborative (CBC), a stakeholder-driven effort established by the AACR, in partnership with FDA and NCI. Read more

 


 

COLLINS ADDRESSES SKEPTICISM ABOUT HUMAN GENOME

Underscores transformational impact on study and treatment of cancer

Ten years after the completion of the first draft of the human genome, the public and media are looking for evidence of its impact on treating disease and wondering whether the large-scale project was worth the financial investment. Read more

 


 

CONGRESSIONAL PANEL HEARS NIH DIRECTOR’S VISION FOR RESEARCH

Collins boasts "striking" progress against cancer and other diseases

NIH Chief, Dr. Francis Collins, took to Capitol Hill last month to tout the pace of innovation and value of scientific discovery fueled by the NIH. Read more

 


 

NATIONAL CANCER ADVISORY BOARD EVALUATES NCI ACTIVITIES

Panel examines clinical trials, drug development and electronic health records

The National Cancer Advisory Board (NCAB) recently convened for two days on the NIH campus to evaluate the direction of the national cancer program. Read more

 


 

 

Top

CPM

                                                                                                    JUNE 20Top10